1141 related articles for article (PubMed ID: 19098898)
21. The AAV9 Variant Capsid AAV-F Mediates Widespread Transgene Expression in Nonhuman Primate Spinal Cord After Intrathecal Administration.
Beharry A; Gong Y; Kim JC; Hanlon KS; Nammour J; Hieber K; Eichler F; Cheng M; Stemmer-Rachamimov A; Stankovic KM; Welling DB; Ng C; Maguire CA
Hum Gene Ther; 2022 Jan; 33(1-2):61-75. PubMed ID: 34128391
[TBL] [Abstract][Full Text] [Related]
22. Recombinant adeno-associated virus serotype 6 (rAAV2/6)-mediated gene transfer to nociceptive neurons through different routes of delivery.
Towne C; Pertin M; Beggah AT; Aebischer P; Decosterd I
Mol Pain; 2009 Sep; 5():52. PubMed ID: 19737386
[TBL] [Abstract][Full Text] [Related]
23. Systemic gene delivery transduces the enteric nervous system of guinea pigs and cynomolgus macaques.
Gombash SE; Cowley CJ; Fitzgerald JA; Lepak CA; Neides MG; Hook K; Todd LJ; Wang GD; Mueller C; Kaspar BK; Bielefeld EC; Fischer AJ; Wood JD; Foust KD
Gene Ther; 2017 Oct; 24(10):640-648. PubMed ID: 28771235
[TBL] [Abstract][Full Text] [Related]
24. Intracerebroventricular delivery of self-complementary adeno-associated virus serotype 9 to the adult rat brain.
Donsante A; McEachin Z; Riley J; Leung CH; Kanz L; O'Connor DM; Boulis NM
Gene Ther; 2016 May; 23(5):401-7. PubMed ID: 26824881
[TBL] [Abstract][Full Text] [Related]
25. Transduction of the central nervous system after intracerebroventricular injection of adeno-associated viral vectors in neonatal and juvenile mice.
Gholizadeh S; Tharmalingam S; Macaldaz ME; Hampson DR
Hum Gene Ther Methods; 2013 Aug; 24(4):205-13. PubMed ID: 23808551
[TBL] [Abstract][Full Text] [Related]
26. Astrocyte-selective AAV gene therapy through the endogenous GFAP promoter results in robust transduction in the rat spinal cord following injury.
Griffin JM; Fackelmeier B; Fong DM; Mouravlev A; Young D; O'Carroll SJ
Gene Ther; 2019 May; 26(5):198-210. PubMed ID: 30962538
[TBL] [Abstract][Full Text] [Related]
27. Subpial Adeno-associated Virus 9 (AAV9) Vector Delivery in Adult Mice.
Tadokoro T; Miyanohara A; Navarro M; Kamizato K; Juhas S; Juhasova J; Marsala S; Platoshyn O; Curtis E; Gabel B; Ciacci J; Lukacova N; Bimbova K; Marsala M
J Vis Exp; 2017 Jul; (125):. PubMed ID: 28745630
[TBL] [Abstract][Full Text] [Related]
28. Severe Toxicity in Nonhuman Primates and Piglets Following High-Dose Intravenous Administration of an Adeno-Associated Virus Vector Expressing Human SMN.
Hinderer C; Katz N; Buza EL; Dyer C; Goode T; Bell P; Richman LK; Wilson JM
Hum Gene Ther; 2018 Mar; 29(3):285-298. PubMed ID: 29378426
[TBL] [Abstract][Full Text] [Related]
29. Preclinical differences of intravascular AAV9 delivery to neurons and glia: a comparative study of adult mice and nonhuman primates.
Gray SJ; Matagne V; Bachaboina L; Yadav S; Ojeda SR; Samulski RJ
Mol Ther; 2011 Jun; 19(6):1058-69. PubMed ID: 21487395
[TBL] [Abstract][Full Text] [Related]
30. Efficient Gene Suppression in Dorsal Root Ganglia and Spinal Cord Using Adeno-Associated Virus Vectors Encoding Short-Hairpin RNA.
Enomoto M; Hirai T; Kaburagi H; Yokota T
Methods Mol Biol; 2016; 1364():277-90. PubMed ID: 26472458
[TBL] [Abstract][Full Text] [Related]
31. AAV-Mediated Gene Delivery to the Spinal Cord by Intrathecal Injection.
Peterson CD; Skorput AGJ; Kitto KF; Wilcox GL; Vulchanova L; Fairbanks CA
Methods Mol Biol; 2019; 1950():199-207. PubMed ID: 30783975
[TBL] [Abstract][Full Text] [Related]
32. Global diffuse distribution in the brain and efficient gene delivery to the dorsal root ganglia by intrathecal injection of adeno-associated viral vector serotype 1.
Iwamoto N; Watanabe A; Yamamoto M; Miyake N; Kurai T; Teramoto A; Shimada T
J Gene Med; 2009 Jun; 11(6):498-505. PubMed ID: 19338016
[TBL] [Abstract][Full Text] [Related]
33. AAV9-Mediated Expression of SMN Restricted to Neurons Does Not Rescue the Spinal Muscular Atrophy Phenotype in Mice.
Besse A; Astord S; Marais T; Roda M; Giroux B; Lejeune FX; Relaix F; Smeriglio P; Barkats M; Biferi MG
Mol Ther; 2020 Aug; 28(8):1887-1901. PubMed ID: 32470325
[TBL] [Abstract][Full Text] [Related]
34. Transduction efficiency of neurons and glial cells by AAV-1, -5, -9, -rh10 and -hu11 serotypes in rat spinal cord following contusion injury.
Petrosyan HA; Alessi V; Singh V; Hunanyan AS; Levine JM; Arvanian VL
Gene Ther; 2014 Dec; 21(12):991-1000. PubMed ID: 25119378
[TBL] [Abstract][Full Text] [Related]
35. Improving single injection CSF delivery of AAV9-mediated gene therapy for SMA: a dose-response study in mice and nonhuman primates.
Meyer K; Ferraiuolo L; Schmelzer L; Braun L; McGovern V; Likhite S; Michels O; Govoni A; Fitzgerald J; Morales P; Foust KD; Mendell JR; Burghes AH; Kaspar BK
Mol Ther; 2015 Mar; 23(3):477-87. PubMed ID: 25358252
[TBL] [Abstract][Full Text] [Related]
36. Comparison of high-dose intracisterna magna and lumbar puncture intrathecal delivery of AAV9 in mice to treat neuropathies.
Bailey RM; Rozenberg A; Gray SJ
Brain Res; 2020 Jul; 1739():146832. PubMed ID: 32289279
[TBL] [Abstract][Full Text] [Related]
37. Use of CRISPR/Cas9-mediated disruption of CNS cell type genes to profile transduction of AAV by neonatal intracerebroventricular delivery in mice.
Torregrosa T; Lehman S; Hana S; Marsh G; Xu S; Koszka K; Mastrangelo N; McCampbell A; Henderson CE; Lo SC
Gene Ther; 2021 Aug; 28(7-8):456-468. PubMed ID: 33612827
[TBL] [Abstract][Full Text] [Related]
38. Systemic delivery of scAAV9 in fetal macaques facilitates neuronal transduction of the central and peripheral nervous systems.
Mattar CN; Waddington SN; Biswas A; Johana N; Ng XW; Fisk AS; Fisk NM; Tan LG; Rahim AA; Buckley SM; Tan MH; Lu J; Choolani M; Chan JK
Gene Ther; 2013 Jan; 20(1):69-83. PubMed ID: 22278413
[TBL] [Abstract][Full Text] [Related]
39. AAV8(gfp) preferentially targets large diameter dorsal root ganglion neurones after both intra-dorsal root ganglion and intrathecal injection.
Jacques SJ; Ahmed Z; Forbes A; Douglas MR; Vigenswara V; Berry M; Logan A
Mol Cell Neurosci; 2012 Apr; 49(4):464-74. PubMed ID: 22425560
[TBL] [Abstract][Full Text] [Related]
40. Adeno-associated virus vectors serotyped with AAV8 capsid are more efficient than AAV-1 or -2 serotypes for widespread gene delivery to the neonatal mouse brain.
Broekman ML; Comer LA; Hyman BT; Sena-Esteves M
Neuroscience; 2006; 138(2):501-10. PubMed ID: 16414198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
